The International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (ADPD)

The AD/PD™ Conference—short for the International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders—is a premier annual event that brings together global experts in neurodegenerative research. AD/PD uniquely integrates discussions on Alzheimer's and Parkinson's diseases, emphasizing their shared and distinct mechanisms. The conference features a comprehensive program, including plenary lectures, symposia, oral and poster presentations, and industry-supported sessions. Key topics encompass early diagnosis, translational research, drug development, biomarkers, and clinical trials. The event attracts over 5,500 participants from more than 70 countries, fostering interdisciplinary collaboration among neuroscientists, clinicians, and industry professionals. It serves as a vital platform for unveiling the latest breakthroughs and advancing therapeutic strategies in the fight against neurodegenerative diseases.